Published in Antimicrob Agents Chemother on March 01, 1999
Genome sequence of the human malaria parasite Plasmodium falciparum. Nature (2002) 37.89
Current advances in detection and treatment of babesiosis. Curr Med Chem (2012) 1.11
Antimalarial activities of peptide antibiotics isolated from fungi. Antimicrob Agents Chemother (2001) 0.91
Molecular surveillance of mutations in the cytochrome b gene of Plasmodium falciparum in Gabon and Ethiopia. Malar J (2006) 0.86
PfMDR2 and PfMDR5 are dispensable for Plasmodium falciparum asexual parasite multiplication but change in vitro susceptibility to anti-malarial drugs. Malar J (2015) 0.82
Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. Antimicrob Agents Chemother (1979) 17.49
A method for testing for synergy with any number of agents. J Infect Dis (1978) 9.52
Transformation with human dihydrofolate reductase renders malaria parasites insensitive to WR99210 but does not affect the intrinsic activity of proguanil. Proc Natl Acad Sci U S A (1997) 5.75
The regulation and nature of the cyanide-resistant alternative oxidase of plant mitochondria. Biochim Biophys Acta (1991) 3.39
Clinical studies of atovaquone, alone or in combination with other antimalarial drugs, for treatment of acute uncomplicated malaria in Thailand. Am J Trop Med Hyg (1996) 3.36
Site of action of the antimalarial hydroxynaphthoquinone, 2-[trans-4-(4'-chlorophenyl) cyclohexyl]-3-hydroxy-1,4-naphthoquinone (566C80). Biochem Pharmacol (1992) 2.74
Interactions of atovaquone with other antimalarial drugs against Plasmodium falciparum in vitro. Exp Parasitol (1995) 2.05
Molecular biology of the alternative oxidase. Plant Physiol (1994) 1.77
Molecular Genetic Alteration of Plant Respiration (Silencing and Overexpression of Alternative Oxidase in Transgenic Tobacco). Plant Physiol (1994) 1.62
566C80: a potent broad spectrum anti-infective agent with activity against malaria and opportunistic infections in AIDS patients. Drugs Exp Clin Res (1991) 1.38
Analysis in yeast of antimalaria drugs that target the dihydrofolate reductase of Plasmodium falciparum. Mol Biochem Parasitol (1997) 1.38
The activity of proguanil and its metabolites, cycloguanil and p-chlorophenylbiguanide, against Plasmodium falciparum in vitro. Ann Trop Med Parasitol (1984) 1.25
Conversion of dihydroorotate to orotate in parasitic protozoa. Biochim Biophys Acta (1979) 1.25
Evaluation of atovaquone in the treatment of patients with uncomplicated Plasmodium falciparum malaria. J Antimicrob Chemother (1995) 1.18
Purification and properties of Plasmodium falciparum malate dehydrogenase. Mol Biochem Parasitol (1992) 1.17
The effects of antimalarials on the Plasmodium falciparum dihydroorotate dehydrogenase. Exp Parasitol (1994) 1.07
566C80, an antimalarial hydroxynaphthoquinone with broad spectrum: experimental activity against opportunistic parasitic infections of AIDS patients. J Protozool (1992) 0.95
Toxicology of gallates: a review and evaluation. Food Chem Toxicol (1987) 0.87
Plasmodium falciparum: cyanide-resistant oxygen consumption. Exp Parasitol (1997) 0.87
Trypanocidal CoQ analogues: their effect on other mitochondrial systems. Comp Biochem Physiol B (1989) 0.84
In vitro activity of atovaquone against the African isolates and clones of Plasmodium falciparum. Am J Trop Med Hyg (1995) 0.83
High-performance liquid chromatographic determination of dihydroorotate dehydrogenase of Plasmodium falciparum and effects of antimalarials on enzyme activity. J Chromatogr (1992) 0.81
Potentiation of the antimalarial activity of atovaquone by doxycycline against Plasmodium falciparum in vitro. Parasitol Res (1997) 0.80
Long-term toxicity study of n-propyl gallate in mice. Food Cosmet Toxicol (1974) 0.80
No evidence of carcinogenicity of D-mannitol and propyl gallate in F344 rats or B6C3F1 mice. Food Chem Toxicol (1987) 0.80
Antimalaria activity of the triple combination of proguanil, atovaquone and dapsone. Acta Trop (1997) 0.78
Nuclear-encoded proteins target to the plastid in Toxoplasma gondii and Plasmodium falciparum. Proc Natl Acad Sci U S A (1998) 4.28
Plastid in human parasites. Nature (1996) 3.25
Plasmodium falciparum: the effects of atovaquone resistance on respiration. Exp Parasitol (2001) 1.08
Recent evolutionary history of American Onchocerca volvulus, based on analysis of a tandemly repeated DNA sequence family. Mol Biol Evol (1994) 1.05
Analysis of apicoplast targeting and transit peptide processing in Toxoplasma gondii by deletional and insertional mutagenesis. Mol Biochem Parasitol (2001) 1.04
Plasmodium falciparum: cyanide-resistant oxygen consumption. Exp Parasitol (1997) 0.87
Symbiotic nitrogen fixation: developmental genetics of nodule formation. Cold Spring Harb Symp Quant Biol (1985) 0.85
Sequence analysis of alfalfa (Medicago sativa) leghemoglobin cDNA and genomic clones. Plant Mol Biol (1991) 0.82
Cloning and characterization of Rhizobium meliloti loci required for symbiotic root nodule invasion. Mol Plant Microbe Interact (1991) 0.78
Nucleotide sequence of a cDNA clone encoding a leghemoglobin from Medicago sativa. Nucleic Acids Res (1989) 0.78
Phylogeny of the large extrachromosomal DNA of organisms in the phylum Apicomplexa. J Eukaryot Microbiol (1996) 0.78
Phylogeny of the large extrachromosomal DNA of organisms in the phylum Apicomplexa. J Eukaryot Microbiol (1996) 0.77
Origin of leukemic relapse after bone marrow transplantation: comparison of cytogenetic and molecular analyses. Blood (1989) 0.76
Targeting of a nuclear encoded protein to the apicoplast of Toxoplasma gondii. J Eukaryot Microbiol (1999) 0.75